Journal of Clinical Pediatrics >
Clinical phenotype expansion and treatment attempts of White-Sutton syndrome: a series of case reports
Received date: 2024-12-30
Accepted date: 2025-10-22
Online published: 2026-01-05
Objective White-Sutton syndrome (WHSUS) is a monogenic genetic disorder with significant phenotypic differences. This study aims to further expand the clinical phenotypic spectrum of WHSUS and explore potential treatment methods for improving symptoms. Methods A retrospective analysis was conducted on the clinical data of four WHSUS patients who visited Children's Medical Center from July 2018 to February 2023. Results The age range of the first diagnosis of the 4 patients was 1-9 years old, 2 boys and 2 girls, all of whom had delayed language and motor development. Patient 1, a girl, exhibited a previously unreported clinical phenotype, tethered cord syndrome (TCS), and concurrent insulin resistance. Patient 2, a girl, visited the doctor due to short stature and poor academic performance. She received growth hormone treatment for 3.5 years. At the age of 12 years and 1 month during the follow-up, her height was 152 cm (P50), and her menstruation was normal. Patient 3, a boy, was treated for delayed language development. Patient 4 was a boy with delayed language development and autistic tendency. All four patients had de novo mutations in the POGZ gene and were diagnosed with WHSUS. Conclusions This study detailedly reported the clinical features of 4 patients with WHSUS, expanding the phenotypic spectrum of WHSUS. Meanwhile, it was the first to report the treatment attempt of growth hormone for a child with WHSUS and short stature, providing a new idea for the symptomatic treatment of this kind of disease.
Key words： White-Sutton syndrome; POGZ gene; tethered cord syndrome
FAN Rui , ZHANG Yining , LI Xin , LI Juan , LI Qun , LI Zhiying , GU Shili , HU Feihan , GAO Shiyang , FENG Biyun , YAO Ruen , WANG Xiumin . Clinical phenotype expansion and treatment attempts of White-Sutton syndrome: a series of case reports[J]. Journal of Clinical Pediatrics, 2026 , 44(1) : 38 -43 . DOI: 10.12372/jcp.2026.24e1398
| [1] | Garde A, Cornaton J, Sorlin A, et al. Neuropsychological study in 19 French patients with White-Sutton syndrome and POGZ mutations[J]. Clin Genet, 2021, 99(3): 407-417. |
| [2] | Donnarumma B, Riccio MP, Terrone G, et al. Expanding the neurological and behavioral phenotype of White-Sutton syndrome: a case report[J]. Ital J Pediatr, 2021, 47(1): 148. |
| [3] | Batzir NA, Posey JE, Song X, et al. Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)[J]. Am J Med Genet A, 2020, 182(1): 38-52. |
| [4] | Nagy D, Verheyen S, Wigby KM, et al. Genotype-phenotype comparison in POGZ-related neuro-developmental disorders by using clinical scoring[J]. Genes (Basel), 2022, 13(1): 154. |
| [5] | Murch O, Jain V, Benneche A, et al. Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature[J]. Eur J Hum Genet, 2022, 30(1): 95-100. |
| [6] | Ibaraki K, Hamada N, Iwamoto I, et al. Expression analyses of POGZ, a responsible gene for neurodevelopmental disorders, during mouse brain development[J]. Dev Neurosci, 2019, 41(1-2): 139-148. |
| [7] | Suliman-Lavie R, Title B, Cohen Y, et al. POGZ deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice[J]. Nat Commun, 2020, 11(1): 5836. |
| [8] | Chebly A, Salem N, Moussallem R, et al. A novel nonsense variant in POGZ expanding the spectrum of White-Sutton syndrome: a case report[J]. Heliyon, 2024, 10(21): e40057. |
| [9] | Lelieveld SH, Reijnders MRF, Pfundt R, et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability[J]. Nat Neurosci, 2016, 19: 1194-1196. |
| [10] | Zhao W, Tan J, Zhu T, et al. Rare inherited missense variants of POGZ associate with autism risk and disrupt neuronal development[J]. J Genet Genomics, 2019, 46(5): 247-257. |
| [11] | Matsumura K, Seiriki K, Okada S, et al. Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes[J]. Nat Commun, 2020, 11: 859. |
| [12] | Markenscoff-Papadimitriou E, Binyameen F, Whalen S, et al. Autism risk gene POGZ promotes chromatin accessibility and expression of clustered synaptic genes[J]. Cell Rep, 2021, 37: 110089. |
| [13] | Cappi C, Oliphant ME, Péter Z, et al. De novo damaging DNA coding mutations are associated with obsessive-compulsive disorder and overlap with Tourette's disorder and autism[J]. Biol Psychiatry, 2020, 87(12): 1035-1044. |
| [14] | Kocaaga A, Yimenicioglu S, ?zdemir Atikel Y, et al. First report of tethered cord syndrome in a patient with Verheij syndrome[J]. Ophthalmic Genet, 2023, 44(4): 396-400. |
| [15] | Han Y, Wang H, Huang Y. Incidence of tethered cord syndrome in pediatric patients with neurofibromatosis type 1[J]. World Neurosurg, 2024, 191: e707-e712. |
| [16] | Kuzucu P, Türkmen T, B?rcek AO. First report of tethered cord syndrome in a patient with Sotos syndrome[J]. BMC Pediatr, 2020, 20(1): 183. |
| [17] | Heath J, Simo Cheyou E, Findlay S, et al. POGZ promotes homology-directed DNA repair in an HP1-dependent manner[J]. EMBO Rep, 2022, 23(1): e51041. |
| [18] | Villalba MF, Chang TC. Congenital corneal opacities as a new feature in an unusual case of White-Sutton syndrome[J]. J AAPOS, 2022, 26(5): 265-268. |
| [19] | Duan J, Ye Y, Liao J, et al. White-Sutton syndrome and congenital heart disease: case report and literature review[J]. BMC Pediatr, 2023, 23(1): 158. |
/
| 〈 |
|
〉 |
